Search results
Jun 21, 2021 · An overview of the NIAID organization including resources about extramural and intramural divisions.
Global Research. The map identifies 133 countries with NIAID-funded activities in fiscal year 2022. NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.
Apr 23, 2020 · The NIAID Strategic Plan for COVID-19 Research has four key priorities. The first involves improving fundamental knowledge of SARS-CoV-2 and COVID-19, including studies to characterize the virus and better understand how it causes infection and disease.
Sep 28, 2021 · The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $36.3 million to three academic institutions to conduct research to develop vaccines to protect against multiple types of coronaviruses and viral variants.
Feb 28, 2018 · What. Developing a universal influenza vaccine — a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic — is a priority for the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
National Institute of Allergy and Infectious Diseases (NIAID) | 41,907 followers on LinkedIn. Join NIAID and make a difference! | This is the official LinkedIn account for the National Institute ...
The National Institute of Allergy and Infectious Diseases (NIAID) provides health information on allergic, infectious, and immunologic diseases. Diseases include food allergy, sinusitis, and genital herpes.
